arBtrage CAPITALIZING MARKETS checking… Sign in

Coherus Oncology, Inc.

CHRS Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.45
▼ -7.9% Today
as of Jun 7, 06:55 ET
Last 30 days -18.08% Apr 28 → Jun 05
$1.41 $1.56 $1.70 $1.85 $1.99 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.57
High
$1.57
Low
$1.44
Volume
$896,893
Avg Vol
$1M
Mkt Cap
$255M
P/E (TTM)
0.73
Beta
52w High
$2.62
52w Low
$0.71
Div Yield
Shares Out
$154M

Overview

52-week range
$0.71
$2.62
39% of range
Avg surprise (last 2)
+2.2%
Avg reaction (last 2)
+8.3%
100% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.49$0.27$1.04$1.80$2.57 Actual $-0.49Actual $-0.41Actual $0.91Actual $-0.11Actual $-0.09Actual $-0.41Est $-0.40Actual $2.57Actual $-0.31Actual $-0.27Est $-0.29 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-57M$36M$128M$220M$313M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.27 $-0.29 +6.9% +34.1% +11.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.31 financials
Mon Jun 30, 2025Jun 2025 $2.57 financials
Mon May 12, 2025Mar/2025 $-0.41 $-0.40 -2.5% +5.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.09 financials
Sun Jun 30, 2024Jun 2024 $-0.11 financials
Sun Mar 31, 2024Mar 2024 $0.91 financials
Sat Sep 30, 2023Sep 2023 $-0.41 financials
Fri Jun 30, 2023Jun 2023 $-0.49 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$4M$4M$3M$3M$3M$2M
Gross profit
Operating income$-36M$-44M$-45M$-45M$-47M$-40M
Net income$-38M$-36M$298M$-57M$-11M$-13M
EPS (diluted)$-0.28$-0.31$2.57$-0.49$-0.09$-0.11

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$115M$89M$103M$217M$82M$126M$98M$159M
Inventory$5M$3M$2M$5M$4M$4M$48M$62M
Total current assets$206M$207M$461M$380M$310M$342M$369M$558M
Total assets$266M$258M$517M$439M$371M$449M$505M$675M
Long-term debt
Total liabilities$187M$197M$429M$320M$555M$581M$593M$759M
Total equity$79M$61M$88M$120M$-183M$-132M$-88M$-84M

Implied volatility — last 90 days

No IV snapshots yet for CHRS.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers